Translation of "durée d'existence prévue " (French → English) :

normal expectancy

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptom ...[+++]s, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

Definition: A disorder characterized by impairment of memory, learning difficulties, and reduced ability to concentrate on a task for more than brief periods. There is often a marked feeling of mental fatigue when mental tasks are attempted, and new learning is found to be subjectively difficult even when objectively successful. None of these symptoms is so severe that a diagnosis of either dementia (F00-F03) or delirium (F05.-) can be made. This diagnosis should be made only in association with a specified physical disorder, and should not be made in the presence of any of the mental or behavioural disorders classified to F10-F99. The disorder may precede, accompany, or follow a wide variety of infections and physical disorders, both cerebral and systemic, b ...[+++]ut direct evidence of cerebral involvement is not necessarily present. It can be differentiated from postencephalitic syndrome (F07.1) and postconcussional syndrome (F07.2) by its different etiology, more restricted range of generally milder symptoms, and usually shorter duration.

estimated elapsed time | EET [Abbr.]

useful life [ estimated useful life | service life | useful life cycle ]

useful life | estimated useful life | expected useful life | service life

accounting life

Estimated Elapsed Time | EET [Abbr.]

Question No. 29 Mr. Peter Julian: With regard to the 267,000 cubic meters of low and intermediate level radioactive wastes that are stored above ground in concrete containers at the Chalk River Laboratories: (a) what is the long-term plan for the containment and safe storage of these wastes; (b) how has the safety of these containers been demonstrated and what is their design life; (c) how has their long term performance been (i) evaluated, (ii) verified; (d) is there an update on the proposed deep geological repository at the Chalk River property and what is (i) the project description, (ii) the project scope; (e) how much will the ...[+++]deep geological repository cost; (f) how has the long term performance been evaluated for the proposed deep geological repository; (g) has a post-closure safety assessment been done; (h) what has been the process for public participation in this project’s development to date; (i) what are the future plans for public participation; and (j) what is the peer review process for this proposed deep geological repository?

However, taking into account the diversity of protection measures under the laws of the Member States, in particular in terms of their duration, and the fact that this Regulation will typically apply in urgent situations, the effects of recognition under this Regulation should, by way of exception, be limited to a period of 12 months from the issuing of the certificate provided for by this Regulation, irrespective of whether the protection measure itself (be it provisional, time-limited or indefinite in nature) has a longer duration.

(Return tabled) Question No. 849 Mr. Matthew Kellway: With regard to the F-35 JSF Program: (a) what is the total Canadian dollar value of benefits received by Canadian industry from Canada’s participation in the F-35 JSF Program (i) from the start of the program until December 1, 2011, (ii) from December 2, 2011 to June 22, 2012; (b) what is the projected value of future contracts, from June 22, 2012, onwards, that come as a result of Canada’s participation in the JSF program; (c) for the contracts in (a), what is the value of each contract that was awarded and on what date was each contract signed; (d) what methodology was used to determine the value of (i) the contracts in (a), (ii) the contracts in (b); (e) was there industry involve ...[+++]ment in determining the values of (i) the contracts in (a), (ii) the contracts in (b); (f) do these valuations include analysis related to the global supply chain; (g) do these valuations include and/or anticipate changes in the domestic supply chain; (h) is the information used in the valuations updated periodically and, if yes, how frequently; (i) was the methodology used to arrive at the values in (a) and (b) independently audited and, if yes, by whom and what was the result of the audit; (j) since the start of the program, have there been discrepancies between projected and actual value of benefits received by Canadian industry; (k) if the answer to (j) is in the affirmative, what are the specific instances and contracts where discrepancies occurred, including (i) the value of each discrepancy, (ii) the name of each company that was meant to receive the benefit; (l) what, if any, changes have been made to the valuations and projection processes used to determine all and any cost projections related to the F-35 JSF program in response to the recommendations in the April 2, 2012, Auditor General's report; (m) for the contracts in (a), is there a means of ensuring that the contracts are being fulfilled as stated in terms ...

1. The period of validity and/or the duration of stay of an issued visa shall be extended where the competent authority of a Member State considers that a visa holder has provided proof of force majeure or humanitarian reasons preventing him from leaving the territory of the Member States before the expiry of the period of validity of or the duration of stay authorised by the visa.